$XENE Xenon Pharmaceuticals Inc. Insider Trading Week 33/2015
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Xenon Pharmaceuticals Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Xenon Pharmaceuticals Inc. in week 33/2015.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 20 2015 | XENE | Xenon Pharmaceutic ... | ROBIN SHERRINGTON | SVP Bus. & Corp. De ... | Option Exercise | M | 4.98 | 2,057 | 10,244 | 0 | |
| Aug 20 2015 | XENE | Xenon Pharmaceutic ... | ROBIN SHERRINGTON | SVP Bus. & Corp. De ... | Option Exercise | M | 4.81 | 1,028 | 4,945 | 0 | |
| Aug 20 2015 | XENE | Xenon Pharmaceutic ... | ROBIN SHERRINGTON | SVP Bus. & Corp. De ... | Payment of Exercise | F | 11.00 | 868 | 9,548 | 3,840 | 4.7 K to 3.8 K (-18.44 %) |
| Aug 20 2015 | XENE | Xenon Pharmaceutic ... | ROBIN SHERRINGTON | SVP Bus. & Corp. De ... | Buy | M | 4.98 | 2,057 | 10,244 | 4,708 | 2.7 K to 4.7 K (+77.59 %) |
| Aug 20 2015 | XENE | Xenon Pharmaceutic ... | ROBIN SHERRINGTON | SVP Bus. & Corp. De ... | Payment of Exercise | F | 11.00 | 434 | 4,774 | 2,651 | 3.1 K to 2.7 K (-14.07 %) |
| Aug 20 2015 | XENE | Xenon Pharmaceutic ... | ROBIN SHERRINGTON | SVP Bus. & Corp. De ... | Buy | M | 4.81 | 1,028 | 4,945 | 3,085 | 2.1 K to 3.1 K (+49.98 %) |
| Aug 20 2015 | XENE | Xenon Pharmaceutic ... | PIMSTONE SIMON N. | President & CEO | Option Exercise | M | 4.98 | 15,432 | 76,851 | 0 | |
| Aug 20 2015 | XENE | Xenon Pharmaceutic ... | PIMSTONE SIMON N. | President & CEO | Option Exercise | M | 4.81 | 5,144 | 24,743 | 0 | |
| Aug 20 2015 | XENE | Xenon Pharmaceutic ... | PIMSTONE SIMON N. | President & CEO | Payment of Exercise | F | 11.00 | 6,508 | 71,588 | 204,205 | 210.7 K to 204.2 K (-3.09 %) |
| Aug 20 2015 | XENE | Xenon Pharmaceutic ... | PIMSTONE SIMON N. | President & CEO | Buy | M | 4.98 | 15,432 | 76,851 | 210,713 | 195.3 K to 210.7 K (+7.90 %) |
| Aug 20 2015 | XENE | Xenon Pharmaceutic ... | PIMSTONE SIMON N. | President & CEO | Payment of Exercise | F | 11.00 | 2,170 | 23,870 | 195,281 | 197.5 K to 195.3 K (-1.10 %) |
| Aug 20 2015 | XENE | Xenon Pharmaceutic ... | PIMSTONE SIMON N. | President & CEO | Buy | M | 4.81 | 5,144 | 24,743 | 197,451 | 192.3 K to 197.5 K (+2.67 %) |
| Aug 20 2015 | XENE | Xenon Pharmaceutic ... | HOLLER FRANK A | Director | Option Exercise | M | 4.98 | 2,057 | 10,244 | 0 | |
| Aug 20 2015 | XENE | Xenon Pharmaceutic ... | HOLLER FRANK A | Director | Payment of Exercise | F | 11.00 | 868 | 9,548 | 174,807 | 175.7 K to 174.8 K (-0.49 %) |
| Aug 20 2015 | XENE | Xenon Pharmaceutic ... | HOLLER FRANK A | Director | Buy | M | 4.98 | 2,057 | 10,244 | 175,675 | 173.6 K to 175.7 K (+1.18 %) |
| Aug 20 2015 | XENE | Xenon Pharmaceutic ... | GOLDBERG Y. PAUL | VP of Clinical Deve ... | Option Exercise | M | 4.98 | 2,057 | 10,244 | 0 | |
| Aug 20 2015 | XENE | Xenon Pharmaceutic ... | GOLDBERG Y. PAUL | VP of Clinical Deve ... | Option Exercise | M | 4.81 | 1,028 | 4,945 | 0 | |
| Aug 20 2015 | XENE | Xenon Pharmaceutic ... | GOLDBERG Y. PAUL | VP of Clinical Deve ... | Payment of Exercise | F | 11.00 | 868 | 9,548 | 6,103 | 7 K to 6.1 K (-12.45 %) |
| Aug 20 2015 | XENE | Xenon Pharmaceutic ... | GOLDBERG Y. PAUL | VP of Clinical Deve ... | Buy | M | 4.98 | 2,057 | 10,244 | 6,971 | 4.9 K to 7 K (+41.86 %) |
| Aug 20 2015 | XENE | Xenon Pharmaceutic ... | GOLDBERG Y. PAUL | VP of Clinical Deve ... | Payment of Exercise | F | 11.00 | 434 | 4,774 | 4,914 | 5.3 K to 4.9 K (-8.12 %) |
| Aug 20 2015 | XENE | Xenon Pharmaceutic ... | GOLDBERG Y. PAUL | VP of Clinical Deve ... | Buy | M | 4.81 | 1,028 | 4,945 | 5,348 | 4.3 K to 5.3 K (+23.80 %) |